Florentia Peintinger

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

W. Fraser Symmans, Florentia Peintinger, Christos Hatzis et al. · Journal of Clinical Oncology · 2007 · 1.7K citations · Full text

Medicine, Oncology, Breast Oncology +16

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

Ana M. González-Angulo, Jennifer K. Litton, Kristine Broglio et al. · Journal of Clinical Oncology · 2009 · 467 citations · Full text

Medicine, Oncology, Pathology +17

Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome

Chafika Mazouni, Florentia Peintinger, Shu Wan-Kau et al. · Journal of Clinical Oncology · 2007 · 308 citations · Full text

Medicine, Oncology, Surgery +17

Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer

W. Fraser Symmans, Christos Hatzis, Christos Sotiriou et al. · Journal of Clinical Oncology · 2010 · 285 citations · Full text

Medicine, Endocrinology, Oncology +16

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group

Elena Provenzano, Veerle Bossuyt, Giuseppe Viale et al. · Modern Pathology · 2015 · 284 citations · Full text

Medicine, Oncology, Pathology +14